Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from ADC rapeutics

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022

Upgrades

Benzinga · Nov 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga · Sep 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Upgrades

Benzinga · Sep 9, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jul 8, 2022

Analyst Ratings for ADC Therapeutics

Analysts have provided the following ratings for ADC Therapeutics (NYSE:ADCT) within the last quarter:

Benzinga · May 10, 2022

RBC Capital Maintains Outperform Rating for ADC Therapeutics: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of ADC Therapeutics (NYSE:ADCT) and lower its price target from $34.00 to $30.00. Shares of ADC Therapeutics are trading down 1.34% over the last 24 hours, at $7.71 per share.

Benzinga · May 10, 2022

Earnings Outlook For ADC Therapeutics

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that ADC Therapeutics will report an earnings per share (EPS) of $-0.70.

Benzinga · May 6, 2022

Read news from The Economist, FT, and more,
with one subscription

How To Attend ADC Therapeutics Q1 2022 Earnings Conference Call

ADC Therapeutics (NYSE:ADCT) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend ADC Therapeutics (ADCT) Conference Call Follow this link to access the live webcast.

Benzinga · May 4, 2022

Earnings Preview For ADC Therapeutics

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate that ADC Therapeutics will report an earnings per share (EPS) of $-0.86.

Benzinga · Mar 2, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Africa

598 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.